RxDoctor Payments Data

Diane Kenkel

Family · Mitchell, SDNPI 1588662688

Payments from drug & device makers

$1,972in general payments, 2019–2025

Across 119 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$345
  • Corium, LLC$241
  • AstraZeneca$182
  • Astellas Pharma US Inc$179
  • Lilly USA, LLC$178
  • Pfizer$135
  • plus $712 from 20 others

What the payments were for

  • Food & beverage$1,88796%
  • Education$854%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,972 in reported general payments places this provider in the 85th percentile of 588 family providers in South Dakota.

See all family providers in South Dakota

Medicare billing

Part B allowed, 2024
$13,807
Medicare patients
39
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin19$29,805
Rosuvastatin Calcium180$3,304
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid19$1,976
Azelastine Hcl23$1,051
Olmesartan Medoxomil22$1,014
Montelukast Sodium75$901
Bupropion XlBupropion Hcl37$645
Ibandronate Sodium15$626
FenofibrateFenofibrate Nanocrystallized25$619
Buspirone Hcl57$617
Duloxetine Hcl44$582
Escitalopram Oxalate64$521
Levothyroxine Sodium78$512
Potassium Chloride48$457
Omeprazole45$429

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$52$29,80519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 588 family providers in South Dakota.

Other family in Mitchell

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →